Is Surgery the Only Option for Early-Stage Prostate Cancer?

A recently reported study lasting 23 years found fewer prostate cancer deaths among early-stage patients treated with radical prostatectomy.
Prostate cancer is men's most common cancer after skin cancer and second in cancer deaths, causing more than 200.000 deaths worldwide annually. Early intervention to prevent progression and treat disease is therefore crucial.
Choosing radical prostatectomy or close monitoring in early disease is difficult for patients and doctors. Radical prostatectomy removes the prostate and seminal vesicles; monitoring avoids intervention until symptoms, using close follow-up and regular checks. The choice is personal. Although surgery is effective, some avoid it because of side effects. Understanding both methods' effects and differences as fully as possible is important.
A recently reported study conducted over 23 years found that, compared with close monitoring, radical prostatectomy for early-stage prostate cancer resulted in fewer prostate cancer deaths in later years. It also found less spread to distant tissues and less need for androgen deprivation (hormone suppression) treatment after surgery. Conversely, urinary leakage and reduced sexual function occurred more frequently among patients undergoing radical prostatectomy.
From 14 centers, 695 early-stage men entered 2 groups: 347 radical prostatectomy and 348 monitoring. Initial average age was 65 and PSA 13 ng/ml, with similar characteristics in the 2 groups (PSA indicates progression). Analyses were grouped by age and tumor risk to assess individual treatment differences. During the first 2 years, visits were every 6 months, then annually through 23 years. By the end of 2012, prostate cancer deaths numbered 63 after surgery and 99 with monitoring; distant spread occurred in 89 versus 138. Monitoring patients needed more palliative treatment, such as radiation and hormonal suppression, offering temporary symptom relief without cure. Surgery produced more urinary leakage and reduced sexual function, although participants' low sexual activity because of age limited its impact. Benefits were greatest below 65 and with intermediate-risk tumors. However, surgical patients over 65 also had substantially less spread and need for palliation.
In conclusion, the study provides important strategic information. Although possible effects make surgery less appealing, its lower mortality and distant spread suggest advantages over close monitoring.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.